Top compounds associated with response to TMED3


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC -0.13 3e-05
mRNA prima-1 CTRPv2 pan-cancer AAC -0.13 3e-05
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA indisulam CTRPv2 pan-cancer AAC -0.14 4e-05
mRNA GW843682X CTRPv2 pan-cancer AAC -0.15 4e-05
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.14 5e-05
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.12 6e-05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 6e-05
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.13 6e-05
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.13 6e-05
Download CSV